| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 03/06/1996 | EP0699907A2 Diagnostic methods soluble CD8 T cell surface antigen and anti-CD8 antibody |
| 03/06/1996 | EP0699766A1 Therapeutic antibody based fusion proteins with platelet factor-4 |
| 03/06/1996 | EP0699758A1 Prototype felv isolates for use in disease models and vaccines |
| 03/06/1996 | EP0699756A1 Novel mutant BR96 antibodies and functional equivalents reactive with human carcinomas |
| 03/06/1996 | EP0699755A2 Method for obtaining modified immunoglobulins with reduced immunogenicity of murine antibody variable domains, compositions containing them |
| 03/06/1996 | EP0699753A2 Protein for the transport of cationic xenobiotic and/or pharmaceutical compounds, DNA sequences coding therefore and its uses |
| 03/06/1996 | EP0699751A1 Antisense complementary to HCV genome |
| 03/06/1996 | EP0699306A1 Assay for cardiac troponin i |
| 03/06/1996 | EP0699237A1 Anti-egfr single-chain fvs and anti-egfr antibodies |
| 03/06/1996 | EP0699236A1 Purified mammalian flt3 ligands and agonists and antagonists thereof |
| 03/06/1996 | EP0699235A1 Animal model for hepatitis virus infection |
| 03/06/1996 | EP0699079A1 Bioactive and/or targeted dendrimer conjugates |
| 03/06/1996 | EP0699078A1 A method to prevent side effects and insensitivity to the therapeutic uses of toxins |
| 03/06/1996 | EP0699077A1 Hiv immunogenic complexes |
| 03/06/1996 | EP0699076A1 Otitis media vaccine |
| 03/06/1996 | EP0652769B1 Vaccines against metazoan parasites |
| 03/06/1996 | EP0550724B1 Vaccine composition for preventing animal abortion caused by Chlamydia psitacci |
| 03/06/1996 | EP0479899B1 Vasodilatory and immune suppressant peptides |
| 03/06/1996 | EP0476059B1 Methods for enhancing the rate of modification of metastable bonds |
| 03/06/1996 | EP0395653B1 Synovial phospholipases |
| 03/06/1996 | EP0315637B1 Polypeptides useful in diagnosis of mycoplasma infections in swine and recombinant-dna methods for manufacturing same |
| 03/05/1996 | US5497228 Laser bevel meter |
| 03/05/1996 | US5496802 Protein; antibody |
| 03/05/1996 | US5496706 Methods and materials for the detection of Staphylococcus aureus |
| 03/05/1996 | US5496554 Purified mite allergen |
| 03/05/1996 | US5496551 Polypeptide immunogens |
| 03/05/1996 | US5496550 Method of reducing the output of Eimeria oocysts from a newborn chick |
| 03/05/1996 | CA2003578C Chlamydia assay |
| 02/29/1996 | WO1996006177A2 Retrovirus-like particles made non-infectious by a plurality of mutations |
| 02/29/1996 | WO1996006174A1 RECOMBINANT DNase B DERIVED FROM STREPTOCOCCUS PYOGENES |
| 02/29/1996 | WO1996006170A1 Method of treating birds with avian myelomonocytic growth factor |
| 02/29/1996 | WO1996006159A1 Unique associated kaposi's sarcoma virus sequences and uses thereof |
| 02/29/1996 | WO1996006114A1 Cytadherence peptides for use in modifying mutual adhesion among eukaryotic cells |
| 02/29/1996 | WO1996006113A1 New immunocontraceptive peptides |
| 02/29/1996 | WO1996006112A1 Antigenic peptides derived from the g protein of rsv for type- and subtype-specific diagnosis of respiratory syncytial virus (rsv) infection |
| 02/29/1996 | WO1996005866A2 Live vaccine for the treatment of tumour diseases |
| 02/29/1996 | WO1996005860A1 A method of treating a patient with a biologically active compound |
| 02/29/1996 | WO1996005859A1 Pneumococcal polysaccharide-recombinant pneumolysin conjugate vaccines for immunization against pneumococcal infections |
| 02/29/1996 | WO1996005858A1 Haemophilus adherence and penetration proteins |
| 02/29/1996 | WO1996005857A1 Device for delivery of substances and methods of use thereof |
| 02/29/1996 | WO1995032735A3 Inverse skewing of the lymphocyte repertoire for therapy and prevention of disease |
| 02/29/1996 | DE4431401A1 Lebendvakzine gegen Tumorerkrankungen Live vaccines against tumors |
| 02/29/1996 | DE4430601A1 Zelladhäsions-Peptide zur Modifikation des Haftungsverhaltens eukaryontischer Zellen untereinander Cell adhesion peptides to modify the adhesion behavior of eukaryotic cells between each other |
| 02/29/1996 | CA2198279A1 Antigenic peptides derived from the g protein of rsv for type- and subtype-specific diagnosis of respiratory syncytial virus (rsv) infection |
| 02/29/1996 | CA2198265A1 New immunocontraceptive peptides |
| 02/29/1996 | CA2198234A1 Live vaccine for the treatment of tumour diseases |
| 02/29/1996 | CA2198207A1 Cell adhesion peptides for use in modifying mutual adhesion among eukaryotic cells |
| 02/29/1996 | CA2197650A1 Method of treating birds with avian myelomonocytic growth factor |
| 02/29/1996 | CA2197562A1 Haemophilus adherence and penetration proteins |
| 02/29/1996 | CA2196892A1 Unique associated kaposi's sarcoma virus sequences and uses thereof |
| 02/29/1996 | CA2188948A1 Device for delivery of substances and methods of use thereof |
| 02/29/1996 | CA2174534A1 Recombinant dnase b derived from streptococcus pyogenes |
| 02/28/1996 | EP0698665A2 Infectious Tick-Borne Encephalitis virus cDNA clone, recombinant vaccine derived therefrom and preparation thereof |
| 02/28/1996 | EP0698216A1 Methods of typing hepatitis c virus and reagents for use therein |
| 02/28/1996 | EP0698116A1 Processes for producing an enzyme |
| 02/28/1996 | EP0698108A1 Adenoviral vectors of animal origin and use thereof in gene therapy |
| 02/28/1996 | EP0698101A1 Hepatitis-c virus type 4, 5 and 6 |
| 02/28/1996 | EP0698100A1 Hybrid picornaviruses expressing chlamydial epitopes |
| 02/28/1996 | EP0698099A1 Method for the culture in vitro of differents stages of tissue parasites |
| 02/28/1996 | EP0698097A1 PRODUCTION OF ANTIBODIES OR (FUNCTIONALIZED) FRAGMENTS THEREOF DERIVED FROM HEAVY CHAIN IMMUNOGLOBULINS OF $i(CAMELIDAE) |
| 02/28/1996 | EP0698091A1 Process for the preparation of immunogens or diagnostic reagents, and immunogens or diagnostic reagents thereby obtainable |
| 02/28/1996 | EP0698042A1 Composition of antibodies against hepatitis b surface antigen |
| 02/28/1996 | EP0697891A1 Polyoxime compounds and their preparation |
| 02/28/1996 | EP0697889A1 COMBINED TREATMENT OF IRON DEPLETION AND IgG ANTIBODY |
| 02/28/1996 | EP0697888A1 Conserved motif of hepatitis c virus e2/ns1 region |
| 02/28/1996 | EP0697880A1 Inhibition of leukocyte adhesion |
| 02/28/1996 | EP0697876A1 Xenograft thymus |
| 02/28/1996 | EP0697857A1 Hookworm anticoagulant |
| 02/28/1996 | EP0511967B1 Medicaments and methods for treating acquired immune deficiency syndrome (aids) and aids-related complex (arc) employing anti-carbohydrate antibodies |
| 02/28/1996 | EP0428629B1 Synthetic polypeptides and antibodies related to epstein-barr virus nuclear antigen |
| 02/28/1996 | EP0362367B1 Osteogenic devices |
| 02/28/1996 | CN1117742A Process for growing porcine reproductive and respiratory syndrome virus and its use in vaccines |
| 02/27/1996 | US5494999 For assaying, purifying or inducing cdw52 antibody |
| 02/27/1996 | US5494808 Defined medium OMPC fermentation process |
| 02/27/1996 | US5494807 NYVAC vaccinia virus recombinants comprising heterologous inserts |
| 02/27/1996 | US5494806 A genetic engineered, hybridized probe consisting of an 18-polynucleotides sequence |
| 02/27/1996 | US5494673 Phosphazene polyelectrolytes as immunoadjuvants |
| 02/27/1996 | US5494672 Pseudomonas peptide composition and method |
| 02/27/1996 | US5494671 Vaccine |
| 02/27/1996 | US5494670 Method of treating ketosis |
| 02/22/1996 | WO1996005315A2 Nucleotide and amino acid sequences of the envelope 1 and core genes of hepatitis c virus |
| 02/22/1996 | WO1996005313A1 VACCINES CONTAINING BORRELIA BURGDORFERI OspG |
| 02/22/1996 | WO1996005311A1 Biologically active porcine somatotropin polypeptide and methods of using the same |
| 02/22/1996 | WO1996005294A1 Method for preparing an influenza virus, antigens obtained and applications thereof |
| 02/22/1996 | WO1996005293A1 Molecular presenting system |
| 02/22/1996 | WO1996005292A1 Antigenically-marked non-infectious retrovirus-like particles |
| 02/22/1996 | WO1996005291A1 Recombinant herpesvirus of turkeys and uses thereof |
| 02/22/1996 | WO1996005229A1 Human-murine chimeric antibodies against respiratory syncytial virus |
| 02/22/1996 | WO1996005228A1 METHOD OF PRODUCING SINGLE-CHAIN Fv MOLECULES |
| 02/22/1996 | WO1996005225A1 Adrenergic receptor |
| 02/22/1996 | WO1996005223A1 Abundant extracellular products and methods for their production and use |
| 02/22/1996 | WO1996005221A1 Calcitonin receptor |
| 02/22/1996 | WO1996004934A1 Retroviral vectors produced by producer cell lines resistant to lysis by human serum |
| 02/22/1996 | WO1996004933A2 Cck antibodies used to improve feed efficiency |
| 02/22/1996 | WO1996004932A1 Novel vaccine adjuvant and vaccine |
| 02/22/1996 | WO1996004931A1 Peroral immunogen composition and process for producing the same |
| 02/22/1996 | WO1996004928A1 Calcitonin gene related peptide receptor |
| 02/22/1996 | WO1996004925A1 Immunoconjugates and humanized antibodies specific for b-cell lymphoma and leukemia cells |
| 02/22/1996 | CA2197712A1 Vaccines containing borrelia burgdorferi ospg |
| 02/22/1996 | CA2197569A1 Nucleotide and amino acid sequences of the envelope 1 and core genes of hepatitis c virus |